October 9, 2015

High Dose Chemo & Stem Cell Transplantation Results in Long-Term Survival for Amyloid Patients

(Eurekalert) – Patients with Light-chain (AL) amyloidosis who are treated with high-dose chemotherapy (melphalan) and autologous (one’s own) stem cell transplantation (HDM/SCT) have the greatest success for long-term survival. These findings, which appear as a “Letter” in the journal Blood, … Read More

Recommended Reading